The Cure Parkinson’s Quarterly Research Grant supports preclinical and clinical research aimed at slowing, stopping, or reversing Parkinson’s disease. It does not fund projects focused only on symptomatic relief. The program prioritizes research that can lead to clinical trials within five years.
This grant is open internationally to academics and commercial entities, provided that commercial costs are justified and aligned with academic expenses. The maximum funding amount for preclinical research is £250,000 (GBP), while clinical trial funding is flexible but requires prior contact with Cure Parkinson’s.
The application process now has two stages: a brief Stage 1 outline submission, followed by a full Stage 2 proposal if invited. Applications are reviewed quarterly by an independent Research Committee, with final funding decisions made by Cure Parkinson’s trustees.
Applicants receive detailed feedback and support throughout the process. The entire grant cycle from initial submission to decision takes about 4-6 months, with clinical trials sometimes taking longer due to iterative review.
Quick Overview of the Cure Parkinson’s Quarterly Research Grant 2025
- Host Country: United Kingdom (international applications accepted)
- Application Deadlines: July 21, 2025; November 3, 2025
- Funding Value: Up to £250,000 for preclinical research; flexible for clinical trials
- Funding Type: Preclinical & clinical research (excluding symptomatic relief)
- Eligibility: Academics and commercial entities worldwide
- Application Process: Two-stage (outline, then full proposal upon invitation)
- Review: Independent Research Committee and peer review
Perks of the Cure Parkinson’s Global Research Grant
- Funding up to £250,000 for promising preclinical projects
- Flexible funding for clinical trials and sub-studies
- Guidance and support during application and review
- Opportunity to advance research aimed at curing Parkinson’s
- Constructive feedback from experts and the Research Committee
- Open to international researchers and institutions
Benefits of the Research Grant to Cure Parkinson’s Disease
- Accelerate the development of disease-modifying therapies for Parkinson’s
- Connect with a global research community focused on Parkinson’s cure
- Access funding to move promising lab research into clinical trials
- Support from a charity that prioritizes translational impact within 5 years
- Improve your research credibility through a rigorous peer-review process
- Foster collaborations that can boost project success and clinical translation
Exclusions of the Research Funding
- Does not fund research only focused on symptom relief
- No funding for basic science or very early drug discovery stages
- Does not cover costs unrelated to the specific funded project
- The Grant Tracker system is discontinued; applications are now manual via email
- Funding only in GBP; commercial costs must be justified and comparable to academic costs
Eligibility Criteria for Cure Parkinson’s Quarterly Research Grant
- Research must focus on disease-modifying therapies to cure Parkinson’s
- Open to preclinical and clinical projects with potential clinical translation
- Projects should aim for clinical trials within five years
- Applicants can be from academic institutions or commercial companies
- Commercial applications must justify costs and align with academic standards
- Must provide clear milestones and deliverables in proposals
- The application must be submitted by the principal investigator representing a legal institution
Important Dates for the Grant for Preclinical Research Funding
- Stage 1 Application Deadline: July 21, 2025
- Second Stage Application Deadline: Upon invitation, aligned with quarterly deadlines
- Next Quarterly Deadline: November 3, 2025
- Research Committee Meetings: Quarterly throughout the year
- Approximate Review Duration: 4-6 months per funding cycle
How to Apply for the Grant Opportunity
- Review the Cure Parkinson’s Research Strategy to ensure your project fits the funding scope.
- Download the Stage 1 application form and relevant documents from their website.
- Complete the Stage 1 application form and attach supporting documents (e.g., drug CV, commercial entity form if applicable).
- Submit your Stage 1 application by email to research@cureparkinsons.org.uk before the deadline.
- Wait for feedback from the Research Committee. If invited, prepare and submit a full Stage 2 application.
- Incorporate any feedback into your Stage 2 application and submit by the next deadline.
- Undergo external peer review and await final funding decision from the trustees.
Required Documents for Cure Parkinson’s Quarterly Research Grant
- Stage 1 Application form
- Drug and compound CV (if applicable)
- Commercial entity form (if applicable)
- Principal Investigator and Co-investigator CVs (optional but recommended)
- Budget breakdown (optional at Stage 1, mandatory at Stage 2)
- Supplementary materials (preliminary data, trial protocols, publications, etc.)
- Signed host institution letter of support (Stage 2)
- Lay summary of research (Stage 2)
